David Guzman

David Guzman

Auto-generated profile, based on publicly available information

David Guzman

London Centre for Nanotechnology and Division of Medicine, University College London, London, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
GHGyeo-Re Han
Gyeo-Re Han
AGArtem Goncharov
Artem Goncharov
MEMerve Eryilmaz
Merve Eryilmaz
Shun YeShun Ye
Shun Ye
Barath PalanisamyBarath Palanisamy
Barath Palanisamy
Aydogan OzcanAydogan Ozcan
Aydogan Ozcan
The landscape of diagnostic testing is undergoing a significant transformation, driven by the integration of artificial intelligence (AI) and machine learning (ML) into decentralized, rapid, and accessible sensor platforms for point-of-care testing (POCT). The COVID-19 pandemic has accelerated the shift from centralized laboratory testing but also catalyzed the development of next-generation POCT platforms that leverage ML to enhance the accuracy, sensitivity, and overall efficiency of point-of-care sensors. This Perspective explores how ML is being embedded into various POCT modalities, including lateral flow assays, vertical flow assays, nucleic acid amplification tests, and imaging-based sensors, illustrating their impact through different applications. We also discuss several challenges, such as regulatory hurdles, reliability, and privacy concerns, that must be overcome for the widespread adoption of ML-enhanced POCT in clinical settings and provide a comprehensive overview of the current state of ML-driven POCT technologies, highlighting their potential impact in the future of healthcare.

2 July 2019 in Bioinformatics
Verified
Journal Article
Open access
PDF file
Raphael SchmittRaphael Schmitt
Raphael Schmitt
SRStephan Rusch
Stephan Rusch
DGDavid Guzman
David Guzman
NMNizar Mahlaoui
Nizar Mahlaoui
SEStephan Ehl
Stephan Ehl
GKGerhard Kindle
Gerhard Kindle
Primary Immunodeficiencies (PIDs) belong to the group of rare diseases. The European Society for Immunodeficiencies (ESID) operates an international research database application for continuous long-term documentation of patient data. The system is a web application which runs in a standard browser. Therefore, the system is easy to access from any location. Technically, the system is based on Gails backed by MariaDB with high standard security features to comply with the demands of a modern research platform. The ESID Online Database is accessible via the official website: https://esid.org/Working-Parties/Registry-Working-Party/ESID-Registry. A demo system is available via: https://cci-esid-reg-demo-app.uniklinik-freiburg.de/EERS with user demouser and password Demo-2019.